These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 25310700)
1. Stathmin is key in reversion of doxorubicin resistance by arsenic trioxide in osteosarcoma cells. Feng T; Qiao G; Feng L; Qi W; Huang Y; Yao Y; Shen Z Mol Med Rep; 2014 Dec; 10(6):2985-92. PubMed ID: 25310700 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of P-gp, Ras and p-ERK1/2 contributes to the arsenic trioxide-induced reduction in drug resistance towards doxorubicin in gastric cancer cell lines. Zhao YY; Yu L; Liu BL; He XJ; Zhang BY Mol Med Rep; 2015 Nov; 12(5):7335-43. PubMed ID: 26459009 [TBL] [Abstract][Full Text] [Related]
3. Decrease in stathmin expression by arsenic trioxide inhibits the proliferation and invasion of osteosarcoma cells via the MAPK signal pathway. Feng T; Xu J; He P; Chen Y; Fang R; Shao X Oncol Lett; 2017 Aug; 14(2):1333-1340. PubMed ID: 28789348 [TBL] [Abstract][Full Text] [Related]
4. Antitumor efficacy of DMSA modified Fe3O4 magnetic nanoparticles combined with arsenic trioxide and adriamycin in Raji cells. Cai X; Cai X; Wang C; Chen B; Hua W; Shen F; Yu L; He Z; Shi Y; Chen Y; Xia G; Bao W; Zhang Y; Wang X J Biomed Nanotechnol; 2014 Feb; 10(2):251-61. PubMed ID: 24738333 [TBL] [Abstract][Full Text] [Related]
5. Low dose of arsenic trioxide inhibits multidrug resistant-related P-glycoprotein expression in human neuroblastoma cell line. Liu L; Li Y; Xiong X; Qi K; Zhang C; Fang J; Guo H Int J Oncol; 2016 Dec; 49(6):2319-2330. PubMed ID: 27840903 [TBL] [Abstract][Full Text] [Related]
6. The overexpression of MRP4 is related to multidrug resistance in osteosarcoma cells. He Z; Hu B; Tang L; Zheng S; Sun Y; Sheng Z; Yao Y; Lin F J Cancer Res Ther; 2015; 11(1):18-23. PubMed ID: 25879330 [TBL] [Abstract][Full Text] [Related]
7. ABCB1-overexpressing MG63/DOX cell xenograft model: maintain the MDR phenotype in vivo. Zhou Z; Wan L; Han Y; Meng X; Yang Q; Li Y; Yu Q; Shen Z; Guo C Pharm Biol; 2013 Aug; 51(8):968-73. PubMed ID: 23735077 [TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide overcomes apoptosis inhibition in K562/ADM cells by regulating vital components in apoptotic pathway. Wang DH; Wei HL; Zhao HS; Hao CY; Min ZH; Liu JM Pharmacol Res; 2005 Nov; 52(5):376-85. PubMed ID: 15979894 [TBL] [Abstract][Full Text] [Related]
9. Pirarubicin inhibits multidrug-resistant osteosarcoma cell proliferation through induction of G2/M phase cell cycle arrest. Zheng SE; Xiong S; Lin F; Qiao GL; Feng T; Shen Z; Min DL; Zhang CL; Yao Y Acta Pharmacol Sin; 2012 Jun; 33(6):832-8. PubMed ID: 22580740 [TBL] [Abstract][Full Text] [Related]
10. Effect of arsenic trioxide on multidrug resistant hepatocellular carcinoma cells. Chan JY; Siu KP; Fung KP Cancer Lett; 2006 May; 236(2):250-8. PubMed ID: 15982806 [TBL] [Abstract][Full Text] [Related]
11. Stathmin is involved in arsenic trioxide-induced apoptosis in human cervical cancer cell lines via PI3K linked signal pathway. Wang X; Ren JH; Lin F; Wei JX; Long M; Yan L; Zhang HZ Cancer Biol Ther; 2010 Sep; 10(6):632-43. PubMed ID: 20657188 [TBL] [Abstract][Full Text] [Related]
12. Alopecurone B reverses doxorubicin-resistant human osteosarcoma cell line by inhibiting P-glycoprotein and NF-kappa B signaling. Xia YZ; Ni K; Guo C; Zhang C; Geng YD; Wang ZD; Yang L; Kong LY Phytomedicine; 2015 Mar; 22(3):344-51. PubMed ID: 25837271 [TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide inhibits the growth of adriamycin resistant osteosarcoma cells through inducing apoptosis. Zhao H; Guo W; Peng C; Ji T; Lu X Mol Biol Rep; 2010 Jun; 37(5):2509-15. PubMed ID: 19701692 [TBL] [Abstract][Full Text] [Related]
14. [Sensitivity of doxorubicin-resistant osteosarcoma cells to doxorubicin regulated by long non-coding RNA NR_036444]. Zhu KP; Zhang CL Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):250-255. PubMed ID: 28550663 [No Abstract] [Full Text] [Related]
15. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Kim BK; Lee YY Cancer Res; 2000 Jun; 60(11):3065-71. PubMed ID: 10850458 [TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide in the mechanism of drug resistance reversal in MCF-7/ADM cell line of human breast cancer. Wang X; Kong L; Zhao J; Yang P Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):339-43. PubMed ID: 12408759 [TBL] [Abstract][Full Text] [Related]
17. Enhanced chemosensitivity by simultaneously inhibiting cell cycle progression and promoting apoptosis of drug-resistant osteosarcoma MG63/DXR cells by targeting Cyclin D1 and Bcl-2. Zhang C; Zhao Y; Zeng B Cancer Biomark; 2012; 12(4):155-67. PubMed ID: 23568006 [TBL] [Abstract][Full Text] [Related]
18. Enhanced chemosensitivity of drug-resistant osteosarcoma cells by lentivirus-mediated Bcl-2 silencing. Zhao Y; Zhang CL; Zeng BF; Wu XS; Gao TT; Oda Y Biochem Biophys Res Commun; 2009 Dec; 390(3):642-7. PubMed ID: 19818735 [TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide induces apoptosis of p53 null osteosarcoma MG63 cells through the inhibition of catalase. Wang Y; Wei Y; Zhang H; Shi Y; Li Y; Li R Med Oncol; 2012 Jun; 29(2):1328-34. PubMed ID: 21308489 [TBL] [Abstract][Full Text] [Related]
20. Pien Tze Huang induces apoptosis in multidrug‑resistant U2OS/ADM cells via downregulation of Bcl‑2, survivin and P-gp and upregulation of Bax. Zhang Y; Wang Q; Niu S; Liu J; Zhang L Oncol Rep; 2014 Feb; 31(2):763-70. PubMed ID: 24337940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]